CVS Health has appointed Michael Mahoney, chair and CEO of medical device manufacturer Boston Scientific to its board of directors, effective Nov. 1.
Mr. Mahoney became CEO of Boston Scientific in 2012 and became board chair in 2016. His career includes more than 25 years of building market-leading medical device, capital equipment and health care IT businesses. Prior to Boston Scientific, Mr. Mahoney served as worldwide chairman of Johnson & Johnson's medical devices and diagnostics division.
"Mike's focus throughout his career — to drive improvements in health outcomes and increase access to care — align with our mission at CVS Health," Karen Lynch, president and CEO, said. "Adding a well-respected health care leader to our board demonstrates our continued focus on strengthening our engagement with consumers to improve their health and well-being."
CVS Health's board on Sept. 21 approved a quarterly dividend of $0.605 cents per share on the common stock of the corporation. The dividend is payable on Nov. 1 to holders of record on Oct. 20.